Perrigo Past Earnings Performance

Past criteria checks 0/6

Perrigo's earnings have been declining at an average annual rate of -53%, while the Pharmaceuticals industry saw earnings growing at 1.7% annually. Revenues have been declining at an average rate of 0.2% per year.

Key information

-53.0%

Earnings growth rate

-52.9%

EPS growth rate

Pharmaceuticals Industry Growth6.0%
Revenue growth rate-0.2%
Return on equity-0.09%
Net Margin-0.09%
Last Earnings Update31 Dec 2023

Recent past performance updates

Recent updates

Benign Growth For Perrigo Company plc (NYSE:PRGO) Underpins Its Share Price

Mar 27
Benign Growth For Perrigo Company plc (NYSE:PRGO) Underpins Its Share Price

These 4 Measures Indicate That Perrigo (NYSE:PRGO) Is Using Debt Extensively

Feb 01
These 4 Measures Indicate That Perrigo (NYSE:PRGO) Is Using Debt Extensively

The Market Doesn't Like What It Sees From Perrigo Company plc's (NYSE:PRGO) Revenues Yet

Dec 28
The Market Doesn't Like What It Sees From Perrigo Company plc's (NYSE:PRGO) Revenues Yet

Perrigo's New Chapter: Its Bold Turnaround Plan Is Worth Buying

Nov 15

The Prognosis For Perrigo

Aug 30

Perrigo Outlook Healed By Repositioning

Jun 12

Perrigo raises dividend by 5% to $0.273/share

Feb 21

Perrigo: Still Languishing But Short-Term Trend Offers Encouragement

Jan 18

Perrigo Non-GAAP EPS of $0.56 misses by $0.11, revenue of $1.1B misses by $40M, lowers FY adj. EPS guidance

Nov 08

Perrigo to invest $170M to expand baby formula manufacturing, buys Nestlé Gateway plant

Nov 01

Perrigo Company plc Is Back On Track

Oct 20

Perrigo to face FDA AdCom meeting for OTC contraceptive

Sep 12

Perrigo responds to 'misleading and inaccurate information' on Zantac claims

Aug 17

Perrigo reports Q2 mixed results; raises FY22 organic net sales growth outlook

Aug 09

Perrigo declares $0.26 dividend

Aug 02

Perrigo: HRA Acquisition To Drive Significant Growth

Jul 20

Perrigo unit seeks FDA over-the-counter approval for birth control pill Opill

Jul 11

Perrigo: The Longer The Base The Higher In Space

Apr 12

The Prognosis For Perrigo

Jan 09

Perrigo: Honing In On A Long Term Bottom

Dec 16

Perrigo Company plc (NYSE:PRGO) Shares Could Be 39% Below Their Intrinsic Value Estimate

Oct 17
Perrigo Company plc (NYSE:PRGO) Shares Could Be 39% Below Their Intrinsic Value Estimate

Perrigo: HRA Acquisition Is A Step In The Right Direction, But Fundamental Concerns Remain

Sep 24

Here's Why Perrigo (NYSE:PRGO) Has A Meaningful Debt Burden

Jul 13
Here's Why Perrigo (NYSE:PRGO) Has A Meaningful Debt Burden

Perrigo Company (PRGO) Presents At Evercore ISI Consumer & Retail Virtual Summit Conference - Slideshow

Jun 21

Are Investors Undervaluing Perrigo Company plc (NYSE:PRGO) By 44%?

Jun 21
Are Investors Undervaluing Perrigo Company plc (NYSE:PRGO) By 44%?

Perrigo Q1 2021 Earnings Preview

May 10

Perrigo - Simplifying To Unlock Appeal

May 02

Perrigo (NYSE:PRGO) Seems To Use Debt Quite Sensibly

Apr 12
Perrigo (NYSE:PRGO) Seems To Use Debt Quite Sensibly

Perrigo Company plc (NYSE:PRGO) Goes Ex-Dividend Soon

Mar 06
Perrigo Company plc (NYSE:PRGO) Goes Ex-Dividend Soon

Is There An Opportunity With Perrigo Company plc's (NYSE:PRGO) 35% Undervaluation?

Mar 04
Is There An Opportunity With Perrigo Company plc's (NYSE:PRGO) 35% Undervaluation?

Revenue & Expenses Breakdown
Beta

How Perrigo makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

NYSE:PRGO Revenue, expenses and earnings (USD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Dec 234,656-41,272123
30 Sep 234,654111,227126
01 Jul 234,630-571,204126
01 Apr 234,559-1311,210125
31 Dec 224,452-1311,161123
01 Oct 224,401-861,168121
02 Jul 224,344-881,170119
02 Apr 224,203-1351,107120
31 Dec 214,139-1311,108122
02 Oct 214,087-2151,146125
03 Jul 214,047-1351,126128
03 Apr 214,015-111,105125
31 Dec 204,088441,100122
26 Sep 204,358771,096148
27 Jun 204,5461431,109162
28 Mar 204,7461401,147175
31 Dec 193,8701591,095119
28 Sep 194,7102471,157173
29 Jun 194,652871,142172
30 Mar 194,6891141,127220
31 Dec 184,7321311,124219
29 Sep 184,8201231,133221
30 Jun 184,9182351,158216
31 Mar 184,9691291,158166
31 Dec 174,9461201,146168
30 Sep 174,994-1,3131,161162
01 Jul 175,025-2,9471,154174
01 Apr 175,127-3,4121,177179
31 Dec 165,281-4,0131,206184
01 Oct 165,308-2,8721,241189
02 Jul 165,320-1,0211,289180
02 Apr 165,395-5091,313196
31 Dec 155,015-21,144186
26 Sep 154,997144912193
27 Jun 154,227136742188
28 Mar 154,217203591163
27 Dec 144,172347487173
27 Sep 144,079190570157
28 Jun 143,914233566153
29 Mar 143,884192528146
28 Dec 133,800256616129
28 Sep 133,703448515120
29 Jun 133,540442474115
30 Mar 133,404431445111

Quality Earnings: PRGO is currently unprofitable.

Growing Profit Margin: PRGO is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: PRGO is unprofitable, and losses have increased over the past 5 years at a rate of 53% per year.

Accelerating Growth: Unable to compare PRGO's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: PRGO is unprofitable, making it difficult to compare its past year earnings growth to the Pharmaceuticals industry (-0.5%).


Return on Equity

High ROE: PRGO has a negative Return on Equity (-0.092%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.